Wegovy is FDA-approved to reduce excess body weight and maintain weight reduction long term in: adults and pediatric patients aged 12 years and older with obesity, and adults with overweight in the presence of at least one weight-related comorbid condition
2017 Dec;140(6):e20173034
Consider meal timing and movement Managing gastroparesis isnt just about what you eat, but also how and when you eat
GLP-1RAs reduce risks of neurocognitive, substance use, cardiovascular and respiratory disorders, but increase risks of gastrointestinal issues, hypotension and pancreatitis
In this scenario, you would also have the opportunity to work with a Medical Review Officer (MRO), a licensed physician trained in substance abuse disorders and drug testing methodology
Their experience with prescription weight loss medications, particularly GLP-1 drugs, ensures you receive proper monitoring and support